Navigation Links
Amyotrophic in Medical News
Stem Cells Could Slacken the Pace of Amyotrophic Lateral Sclerosis Disease, Study
United States researchers have explained the recent improvements in the treatment of amyotrophic lateral sclerosis (ALS), which is capable of slowing// the onset of paralysis. It is observed that people with the disease die a slow death when the muscles in charge of breathing actually stop working....Molecular Therapy Holds Promise in the Treatment of Amyotrophic Lateral Sclerosis
Researchers from the University of California, San Diego (UCSD) School of Medicine, the Center for Neurologic Study and Isis Pharmaceutical Corporation have created// and tested molecular therapy in animals which they feel will assist in the treatment of amyotrophic lateral sclerosis (ALS), or Lou ...iPierian Appoints Dr. Chad Cowan and Dr. Konrad Hochedlinger to Scientific Advisory Board
...artners, MPM Capital and FinTech Global Capital. The initial focus of the company is in neurodegeneration, particularly spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS) and Parkinson's disease as well as in cardiovascular disease, where iPierian has a collaboration with The Gladstone Institute ...Bally Total Fitness Flexes Fundraising Muscle to Fight ALS
... Augie's Quest , MDA's fast-track ALS research initiative, is an aggressive, cure-driven effort singularly focused on finding treatments and cures for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). For more information on Augie's Quest or to make a donation, please visit www.augiesquest.org or ...Insmed Provides Update on Supply of IPLEX(TM)
... and the remainder around the rest of the world. Most of the patients receive IPLEX(TM) pursuant to a court-ordered Extended Access Program (EAP) for amyotrophic Lateral Sclerosis (ALS) in Italy. The 12 U.S. patients are being treated for ALS under single patient Investigational New Drug applications approved ...Cleveland Clinic Lou Ruvo Center for Brain Health Opens for Business
... center designed to advance the research, early detection and treatment of neurological diseases, including Alzheimer's, Huntington's, Parkinson's and amyotrophic Lateral Sclerosis (ALS). "We still have much more to accomplish, but welcoming patients and caregivers is a truly significant benchmark for...DynaVox Systems LLC Merges with Blink Twice
... gives a voice to the millions of people who are unable to use speech as their primary means of communication due to the effects of conditions such as amyotrophic lateral sclerosis (ALS or Lou Gehrig's Disease), stroke, traumatic brain injury, cerebral palsy, Parkinson's Disease, autism and mental retardation. ...Growth Hormone May Build Muscle in Older Men
... in Glasgow, Scotland. The growth hormone may also benefit patients who can't do intensive exercise because of diseases such as muscular dystrophy, amyotrophic lateral sclerosis (ALS), kidney disease or cancer. MGF may even help slow muscle loss among astronauts who spend long hours in zero gravity during spa...Finding Raises Hope for Treating ALS
...et and symptoms could be targeted for therapy, study suggests,, MONDAY, JUNE 15 (HealthDay News) -- Researchers now believe that ALS, or amyotrophic lateral sclerosis, starts well before its debilitating symptoms appear, a finding that they say could eventually lead to an effective treatment. P...New Jefferson study may redefine how a chronic auto-immune disease is diagnosed
...diagnostic Neuromuscular Lab at JHN, led the study which looked at the number of demyelinating features that are needed to differentiate between CIDP, amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) and diabetic neuropathy. His research suggests a minimum number of three demyelinating features can ...Amyotrophic in Medical Technology
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
LONDON, June 1 /PRNewswire/ -- Privately owned UK biotech company Daval International Limited ( http://www.davalinternational.com ) has been informed by Australia's Therapeutic Goods Administration (TGA) that its innovative anti-inflammatory agent AIMSPRO(R) has been awarded Orphan Status for ...SB-509 to be Evaluated in Repeat-Dosing Study in Subjects with ALS RICHMOND, Calif., Sept. 3 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that it has opened a Phase 2 clinical trial (SB-509-801) to evaluate its drug, SB-509, in subjects with ALS, a pr...
Company Received $5.2 Million in Cost Recovery from EAP in 2007 RICHMOND, Va., Jan. 24 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics and biopharmaceuticals, today provided an update on the IPLEX(TM) Expanded Access Program (EAP) in Italy for the t...
Selected Therapy Can Advance to Phase III Clinical Trial PALO ALTO, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late-stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, today announ...
PALO ALTO, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late-stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today that data related to the Company's Amyotrophic Lateral Scler...
Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
... by the Company with research programs currently underway include: Ischemic Spastic Paraplegia, Traumatic Spinal Cord Injury, Huntington's disease and amyotrophic Lateral Sclerosis (ALS). The Company filed an IND (Investigational New Drug) application with the FDA for ALS clinical trials in December, 2008, and h...Neuralstem's ALS Trial on Clinical Hold
... by the Company with research programs currently underway include: Ischemic Spastic Paraplegia, Traumatic Spinal Cord Injury, Huntington's disease and amyotrophic Lateral Sclerosis (ALS). In pre-clinical work, the company's cells have extended the life of rats with ALS (Lou Gehrig's disease) as reported th...Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives
...factor (VEGF) with three Phase 2 clinical trials ongoing for the treatment of diabetic neuropathy (DN) and one to evaluate its use in the treatment of amyotrophic lateral sclerosis (ALS). We have also advanced our preclinical pipeline and expect to file Investigational New Drug (IND) application for the first of......ndentify the altered expression of genes and proteins, at the onset of, and throughout the progression of the fatal neurodegenerative disease known as amyotrophic lateral sclerosis (ALS, commonly known as Lou Gehrig's disease). The knowledge generated through this effort will be crucial to the identification of ...
...To read the stories of successfully implanted patients, visit http://www.synapsebiomedical.com/news/success/ . ALS Clinical Trials Also Underway amyotrophic Lateral Sclerosis (ALS), commonly referred to as Lou Gehrig's disease, is a rapidly progressing, incurable and fatal neuromuscular disease characteriz...
Amyotrophic in Medical Definition
...Synuclein
Tauopathies (multiple)
Microtubule-associated protein tau
Frontotemporal lobar degeneration (FTLD) (Ubi+, Tau-)
TDP-43
amyotrophic lateral sclerosis (ALS)
Superoxide dismutase, TDP-43
Huntington's disease and other triplet repeat disorders (multiple)
Proteins with tandem...
Amyotrophic in Medical Dictionary
... amyotrophic lateral sclerosis is a form of motor neuron ... the central nervous system that control... amyotrophic lateral sclerosis (ALS) — Comprehensive overv... of this degenerative neurological condition. amyotrophic lateral sclerosis (ALS), also known as Lou Ge...
... Hyperlinked overview of amyotrophic lateral sclerosis ( ALS ) with symptoms, dia...tudies/potential treatments for ALS , or ... amyotrophic lateral sclerosis ( ALS ), also known as Lou Ge...mation, articles, clinical trials, and more about amyotrophic lateral sclerosis for both patients and health ...
... Hyperlinked overview of amyotrophic lateral sclerosis ( ALS ) with symptoms, dia...tudies/potential treatments for ALS , or ... amyotrophic lateral sclerosis ( ALS ), also known as Lou Ge...mation, articles, clinical trials, and more about amyotrophic lateral sclerosis for both patients and health ...
Amyotrophic in Biological News
UMMS researchers isolate first 'neuroprotective' gene in patients with amyotrophic lateral sclerosis
WORCESTER, Mass. A genetic variant that substantially improves survival of individuals with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been indentified by a consortium of researchers led by John Landers, PhD, Associate Professor of Neurology and Robert Brown, MD...'Show me the money!' MDA greenlights grants
...ded has created the basis for progressive treatments of muscular dystrophy, amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, and spinal muscular atrop...r three years to study how defects in the blood-brain barrier contribute to amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. Ilieva hopes to find a wa...Brain-computer interface, developed at Brown, begins new clinical trial
...ial is part of a larger BrainGate research effort, the ultimate goal of which is to help patients with spinal cord injury, stroke, muscular dystrophy, amyotrophic lateral sclerosis (ALS) or limb loss turn their thoughts into actions, restoring independence, mobility, and communication. The work to date with Brai...Brain protein central to both Parkinson's, drug addiction identified
... electrical signals. Astrocytes' role in Parkinson's is no surprise to brain experts who have also identified them as a player in Alzheimer's disease, amyotrophic lateral sclerosis, epilepsy, and other diseases. "Astrocytes are definitely much more than support cells in the brain," said Kim Tieu, Ph.D., a cor...New light on bipolar treatment drugs
...thium could become very important over the next few years." Lithium is currently under clinical trial for the treatment of neurogenerative disorder amyotrophic lateral sclerosis (ALS) The research, funded by the Wellcome Trust, is published in the journal Disease Models and Mechanisms . ...Researchers use brain interface to post to Twitter
...wide who aim to perfect a communication system for users whose bodies do not work, but whose brains function normally. Among those are people who have amyotrophic lateral sclerosis (ALS), brain-stem stroke or high spinal cord injury. Some brain-computer interface systems employ an electrode-studded cap wired ...Caffeine appears to be beneficial in males -- but not females -- with Lou Gehrig's disease
...f ALS. The study, entitled Caffeine Reduces Motor Performance and Antioxidant Enzyme Capacity in the Brain of Female G93A Mice, An Animal Model of amyotrophic Lateral Sclerosis (ALS) was conducted by Rajini Seevaratnam1 supervised by Mazen J. Hamadeh1,2 , and co-authored by Sandeep Raha2 and Mark A. Tarnopol...Caffeine appears to be beneficial in males -- but not females -- with Lou Gehrig's disease
...f ALS. The study, entitled Caffeine Reduces Motor Performance and Antioxidant Enzyme Capacity in the Brain of Female G93A Mice, An Animal Model of amyotrophic Lateral Sclerosis (ALS) was conducted by Rajini Seevaratnam1 supervised by Mazen J. Hamadeh1,2 , and co-authored by Sandeep Raha2 and Mark A. Tarnopol...Jefferson researcher awarded Landenberger Foundation grant for ALS research
...s Jefferson University was recently awarded a Margaret Q. Landenberger Research Foundation grant to identify why drug therapies that showed promise in amyotrophic Lateral Sclerosis (ALS) mouse models have proven unsuccessful in human clinical trials. Dr. Pasinelli and her research team will closely examine crit...Blood test predicts chance of dementia
...D. New results indicate that progranulin also plays a role in the death of brain cells in other diseases of the brain, such as Alzheimer's disease and amyotrophic Lateral Sclerosis (ALS). Predictive test On the basis of their research, Kristel Sleegers, a scientist in Van Broeckhoven's team, has develope...Amyotrophic in Biological Technology
iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming
...rtners, MPM Capital and FinTech Global Capital. The initial focus of the company is in neurodegeneration, particularly spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS) and Parkinson's disease as well as in cardiovascular disease, where iPierian has a collaboration with The Gladstone Institute ...Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Games on July 4th
...ute (ALS TDI). Corey will attend both baseball games to raise awareness of amyotrophic lateral scleroses (ALS, Lou Gehrig's disease) a neurodegenerative disease o... Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), as soon as possible. Focuse...Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy
...d, "IPLEX(TM) continues to demonstrate a strong safety profile and we believe it offers a potential treatment in multiple therapeutic areas, including amyotrophic Lateral Sclerosis. Beyond IPLEX(TM), our current cash reserves of approximately $120 million provides us with a significant opportunity to continue g...iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board
...cal needs. We will look to Dr. Goodman's extensive knowledge and leadership in neurology to help advance our proprietary neurodegenerative programs in amyotrophic lateral sclerosis, spinal muscular atrophy and Parkinson's disease," said John P. Walker, chief executive officer of iZumi. "Over the next few months,...Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States
...mlb.com . About ALS TDI The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), as soon as possible. Focused on meeting this urgent unmet medical need, ALS TDI executes a robust disc...Insmed Announces First Quarter 2009 Financial Results
...cond quarter of 2009; The FDA announced that it would allow Insmed to provide access to IPLEX(TM) for investigational use in patients with amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease). Insmed will conduct a controlled clinical trial under an Investigational New Drug application; ......aufield and Byers and Highland Capital Partners. The initial focus of the company is in neurodegeneration, particularly spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS) and Parkinson's disease as well as in cardiovascular disease, where iZumi has a collaboration with The Gladstone Institute of ...
...ve therapeutic development effort in the world focused entirely on stopping amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease). ALS is a progressive neurode... Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) as soon as possible. Focused...
...t candidate of this therapeutic platform is a spinal cord cell line. When implanted into animal models, the cells have extended the lives of rats with amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and reversed paralysis in ischemic spastic paraplegia models. In December 2008, Neuralstem filed an In...
Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)
...agreement, Insmed will continue to be responsible for the IPLEX(TM) EAP for amyotrophic Lateral Sclerosis (ALS) in Italy, as well as all IPLEX(TM)-related activiti...PLEX(TM) to patients that are suffering from debilitating diseases, such as amyotrophic Lateral Sclerosis, and have no other medical options," said Dr. Geoffrey Al...Amyotrophic in Biological Products
Mouse Anti-Human ALS2CR8 Polyclonal Antibody, Unconjugated from Novus Biologicals
Description:... Mouse polyclonal antibody to ALS2CR8 - amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8...Company:Novus Biologicals
Other TagsOther Contents
ProlexysPluristemPharmassetHaemacureAmbriliaGeronLumiracoxibPrexigeSolsticeVeroScienceSalixNovelosJavelinTrophos
(Date:5/20/2013)... MONDAY, May 20 (HealthDay News) -- A child whose ... relatively higher risk for developing a respiratory infection before ... Researchers looked at data involving nearly 1,300 pairs of ... began study participation while in their first trimester of ... About 6 percent of the mothers lived within 100 ...
(Date:5/20/2013)... In celebration of National Women’s Health Week and ... The Feinstein Institute for Medical Research and ... in Science and Medicine (AWSM) , hosted its second ... business and community leaders from the region attended the ... science. , “Women face unique barriers to success ...
(Date:5/20/2013)... emergency departments play a growing role in the U.S. ... hospital admissions and serving increasingly as an advanced diagnostic ... RAND Corporation study. , While often targeted as the ... remain an important safety net for Americans who cannot ... slowing the growth of health care costs, according to ...
(Date:5/20/2013)... ANN ARBOR, Mich. As high schoolers prepare for ... a "study drug" -- a prescription stimulant or amphetamine ... University of Michigan poll shows only one in 100 ... teen has used a study drug., Study drugs refer ... attention deficit hyperactivity disorder (ADHD); commonly prescribed medicines in ...
(Date:5/20/2013)... 2013) Wolters Kluwer Health is ... Wilkins (LWW) published journals won 13 ASHPE awards ... member articles and publications for editorial, design, print ... honor to be recognized year after year for ... the industry with quality, depth, and impact," said ...
Breaking Medicine News(10 mins):Health News:Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3Health News:Hospital emergency departments gaining in importance, study finds 2Health News:Hospital emergency departments gaining in importance, study finds 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2Health News:Wolters Kluwer Health receives 13 awards from the ASHPE 2[0] Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children[0] North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week[0] Hospital emergency departments gaining in importance, study finds[0] 1 in 10 teens using 'study drugs,' but parents aren't paying attention[0] Wolters Kluwer Health receives 13 awards from the ASHPE
(Date:5/16/2013)... Access to Research Careers) Program has announced the ... Biology (SDB) 72nd Annual Meeting in Cancun, Mexico ... to promote the entry of students, postdoctorates and ... the basic science community and to encourage the ... Annual Meeting. , Awards are given to poster/platform ...
(Date:5/16/2013)... BOSTON The endothelium, the cellular layer lining ... just a few hundred nanometers in thickness, this ... stretch and tissue compression to create a unique ... necessary to partition tissues from the body,s circulatory ... when the barrier must be physically breached ...
(Date:5/16/2013)... are about 23 million years old give unprecedented ... order, one of the most species-rich groups among ... paleontologist Professor Bettina Reichenbacher from the Division of ... and Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) in Munich ... fish fossils which they assign to the group ...
Breaking Biology News(10 mins):Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |